Glasdegib Maleate Patent Expiration
Glasdegib Maleate is Used for treating newly-diagnosed acute myeloid leukemia in adult patients over 75 years old or with comorbidities. It was first introduced by Pfizer Inc
Glasdegib Maleate Patents
Given below is the list of patents protecting Glasdegib Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Daurismo | US10414748 | Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate | Apr 13, 2036 | Pfizer |
| Daurismo | US11168066 | Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate | Apr 13, 2036 | Pfizer |
| Daurismo | US11891372 | Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate | Apr 13, 2036 | Pfizer |
| Daurismo | US8148401 | Benzimidazole derivatives | Jan 30, 2031 | Pfizer |
| Daurismo | US8431597 | Benzimidazole derivatives | Jun 29, 2028 | Pfizer |
Glasdegib Maleate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List